Unilever McCormick deal faces phase 2 investigation in the UK
Unilever (UL) and McCormick (MKC) face a phase 2 UK investigation over their $44.8bn merger. The Competition and Markets Authority (CMA) cites concerns about competition in dry ingredient mixes and sauces. The companies have until November 18 to address these issues. The merger cleared US antitrust review in October.
How this was made
The 30-second read
Why it matters
Regulatory risk is the primary new factor; investors must reassess deal timelines and probability of completion.
Market read
The CMA's phase‑2 investigation introduces material uncertainty to a high‑value cross‑border merger, likely affecting both stocks and the broader M&A climate.
What to watch
Potential concessions on product lines or divestitures could mitigate competition concerns and preserve deal value.
Background
Unilever and McCormick announced a $44.8bn merger in March 2026. The US antitrust review cleared, but the UK CMA has now moved to phase‑2.
Ticker impact
Unilever faces a UK phase‑2 CMA investigation that could block its $44.8bn merger with McCormick.
downward pressure as investors price in possible deal delay or termination
Phase‑2 investigations are rare and often lead to concessions or deal break‑ups, which historically cause stock declines.
Market effects
The food‑ingredients sector may see heightened regulatory scrutiny on consolidation moves.
UK markets could react to the CMA's stance, influencing other pending consumer‑goods deals.
Global investors tracking large M&A will monitor the outcome, potentially affecting broader merger sentiment.
Counterpoint
If the CMA grants an acceptable undertaking, the merger could proceed, unlocking synergies and boosting both stocks.
Key entities
- CompanyUnilever PLC
Global consumer goods group, US‑listed ADR UL.
- CompanyMcCormick & Company
Spice and flavor manufacturer, US ticker MCK.
- RegulatorUK Competition and Markets Authority (CMA)
UK competition regulator reviewing the merger.
